Tavi Yehudai

Tavi Yehudai most recently served as Managing Director and Co-Portfolio Manager at Great Point Partners, a leading health care investment firm focused on growth buyouts and public life sciences investment strategies. In his role, he was responsible for sourcing, executing, and managing investments in both private and public health care companies, overseeing capital deployment, and supporting management teams across the portfolio.

Yehudai’s investment expertise spans the health care sector, with a particular focus on biotechnology, pharmaceutical services, and life sciences companies. He played a key leadership role in the investment of Great Point’s growth buy-out funds, such as GPP III, which aimed at acquiring and scaling growing companies in pharmaceutical services and related segments. Additionally, he was involved with the BioMedical Value Fund, which invests in small and mid-cap publicly traded biotechnology and life sciences companies.

Prior to joining Great Point Partners in 2004, Yehudai worked as an analyst at CIBC World Markets. He holds an undergraduate degree from Washington University in St. Louis. Over his two-decade career, he has contributed to the growth and successful exits of numerous health care companies, providing strategic guidance and capital to drive operational improvements and innovation across the sector.